Search clinical trials for: Nonresponders

Total 27 results

The Affiliated Hospital of Xuzhou Medical University

Recruiting

Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM

Type 2 Diabetes Mellitus | Susceptibility, Genetic

China
University of Arizona
National Institute on Deafness and Other Communication Disorders (NIDCD)

Not yet recruiting

Addressing Treatment Nonresponders

Language Development Disorders
Tomsk National Research Medical Center of the Russian...

Not yet recruiting

Left Bundle Branch Pacing on Outcomes and Ventricular Remodeling in Biventricular CRT Nonresponders (RESCUE)

Heart Failure | Left Bundle-Branch Block | Ischemic Cardiomyopathy | Left Ventricular Dysfunction | Non-ischemic Dilated Cardiomyopathy | Left Ventricle Remodeling

Russian Federation
China Medical University Hospital

Recruiting

NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder

Major Depressive Disorder

Taiwan
Lovoria Williams
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Enhanced DPP-GLB to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention.

Diabetes

United States
F.D. Roosevelt Teaching Hospital with Policlinic...

Recruiting

Fecal Microbial Transplantation in Severe Alcoholic Hepatitis (FMTH7)

Alcoholic Hepatitis

Slovakia
University of Wisconsin, Madison

Completed

HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders

Healthcare Worker, Hepatitis B Vaccine, Nonresponder

United States
Tulane University School of Medicine
BioMarin Pharmaceutical

Completed

Evaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression Kuvan Nonresponders (IST)

Phenylketonuria | Behavior and Behavior Mechanisms | PAH Gene Expression

United States
University of Maryland, Baltimore
Baltimore Veterans Affairs Medical Center

Completed

Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders (HBR2)

HIV Infections | Hepatitis B | Vaccine Response Impaired

United States
National Institutes of Health Clinical Center (CC)

Completed

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

HIV Infection | Hepatitis C Infection

United States
Cristian Alvarez
Universidad de La Frontera

Completed

Nonresponders by the Session Order Factor

Morbid Obesity | Sports Physical Therapy

Chile
Merck Sharp & Dohme LLC

Completed

Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514) (PROVIDE)

Hepatitis C, Chronic
University of Sao Paulo

Unknown

Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients (ARIQUELI-ME)

Bipolar Disorder

Brazil
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company; United States Department of Defense

Completed

Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)

Lung Cancer

United States
Florida International University
National Institute of Mental Health (NIMH)

Completed

Attention Bias Modification Training for Child Anxiety CBT Nonresponders

Anxiety Disorders

United States
Medical University of Vienna

Completed

Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders (NRSily)

Hepatitis C

Austria
Samsung Medical Center

Unknown

Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype

Depression

Korea, Republic of
University Hospitals, Leicester

Completed

A Study of Triple-site Ventricular Pacing in Patients Who Have Not Responded to Conventional Dual Ventricular Site Cardiac Resynchronization Therapy (TRIVENT)

Heart Failure

United Kingdom
University of Sao Paulo

Unknown

Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients (ARIQUELI)

Bipolar I Disorder

Brazil
University of Modena and Reggio Emilia
Merck Sharp & Dohme LLC

Unknown

Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC) (MEN_BOC)

Menopause | Chronic Hepatitis C

Italy
Jiangsu Province Centers for Disease Control and...
Shenzhen Kangtai Biological Products Co., LTD

Completed

The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines

Hepatitis b
Brooke Army Medical Center
InterMune

Completed

Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin

Hepatitis C

United States
Sociedad Andaluza de Enfermedades Infecciosas

Completed

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Liver Cirrhosis | HIV Infection | Hepatitis C Virus

Spain
Foundation for Liver Research

Completed

Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders (SCIN-C)

Chronic Hepatitis C

Netherlands
InterMune

Completed

CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)

Chronic Hepatitis C

United States
Hepasome Pharmaceuticals

Unknown

HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients

Chronic Hepatitis C

India
Beth Israel Medical Center
InterMune

Completed

Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy

Hepatitis C

United States

Search clinical trials for: Nonresponders

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations